Premium
Papers to be published in forthcoming issues. Toward more effective antifungal therapy: the prospects of combination therapy. Myeloma cells can directly contribute to the pool of RANKL in bone bypassing the classic stromal and osteoblast pathway of osteoclast stimulation. Haematogones in the peripheral blood of adults: a four‐colour flow cytometry study of 102 patients. Plasma levels of von Willebrand factor regulate ADAMTS‐13, its major cleaving protease. Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen. Direct interaction between the Lu/B‐CAM adhesion glycoproteins and erythroid spectrin. Applications of murine and humanized chimeric monoclonal antibodies for red cell phenotyping. Impact of pre‐analytical handling on bone marrow mRNA gene expression. Identification of protein S α gene mutations including four novel mutations in eight unrelated patients with protein S deficiency
Author(s) -
Kontoyiannis D. P.,
Lewis R. E.,
Lai F. P. L.,
ColeSinclair M.,
Cheng W.J.,
Quinn J. M. W.,
Gillespie M. T.,
Sentry J. W.,
Schneider H.G.,
Kroft S. H.,
Asplund S. L.,
McKenna R. W.,
Karandikar N. J.,
Mannucci P. M.,
Capoferri C.,
Canciani M. T.,
Bord S.,
Frith E.,
Ireland D. C.,
Scott M. A.,
Craig J. I. O.,
Compston J. E,
Kroviarski Y.,
El Nemer W.,
Gane P.,
Rahuel C.,
Gauthier E.,
Lecomte M. C.,
Cartron J. P.,
Colin Y.,
Le Van Kim C.,
Lee E.,
Burgess G.,
Halverson G. R.,
Huang T. J.,
Reid M. E.,
Breit S.,
Nees M.,
Schaefer U.,
Pfoersich M.,
Hagemeier C.,
Muckenthaler M.,
Kulozik A. E.,
Okada H.,
Takagi A.,
Murate T.,
Adachi T.,
Yamamoto K.,
Matsushita T.,
Takamatsu J.,
Sugita K.,
Sugimoto M.,
Yoshioka A.,
Yamazaki T.,
Saito H.,
Kojima T.
Publication year - 2004
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2004.005016.x
Subject(s) - rankl , multiple myeloma , medicine , genetic enhancement , bone marrow , cancer research , osteoclast , denosumab , immunology , chemistry , osteoporosis , gene , activator (genetics) , biochemistry , receptor